<DOC>
	<DOCNO>NCT01556932</DOCNO>
	<brief_summary>This randomize clinical trial study ABH ( lorazepam , diphenhydramine hydrochloride , haloperidol ) gel patient nausea . ABH gel , absorbed skin , may effective treatment nausea vomit . The general purpose research study improve treatment nausea vomiting .</brief_summary>
	<brief_title>Randomized Trial Effectiveness Topical `` ABH Gel '' v . Placebo Cancer Patients With Nausea</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . The primary outcome change numeric rating scale self-reported nausea 0-10 scale baseline 60 minute treatment . OUTLINE : All individual eligible randomize sequence treatment : either placebo-ABH ABH-placebo . The randomization list generate Study Biostatistician . Neither patient investigator knowledge actual content Drug A B , study double-blinded , placebo control . Drug A : The dose drug 1.0 mL dose 2 mg lorazepam , 25 mg diphenhydramine , 2 mg haloperidol pluronic lecithin organogel . It rub volar surface wrist subject , 2 minute do clinical practice , time 0 . Drug B : equivalent ABH . Subjects rub 1 mL first drug , Drug A gel , wrists 2 minute . Subjects ask rate complete nausea Memorial Symptom Assessment Scale ( CMSAS ) . At time 60 two option occur . One , effect first drug one hour , patient receive second drug . If effect one hour second drug , patient stop study resume normal treatment nausea . Or two , first gel reduces nausea 1 point 0-10 scale , subject wait 4 hour apply next gel . At point , study procedure repeat . After treatment , patient follow 8 hour . Subjects ask rate nausea 0 ( nausea ) 10 ( bad possible nausea ) scale baseline , 60 , 120 , 180 , 240 minute . Subjects complete Memorial Symptom Assessment Scale ( CMSAS ) , reliable valid instrument assess relevant symptom include lack energy , lack appetite , pain , dry mouth , weight loss , feel drowsy , shortness breath , constipation , difficulty sleeping , difficulty concentrating , nausea .</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Lorazepam</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>English speaking No allergy drug Able complete form If woman childbearing age , agree use contraception ; woman offer pregnancy test trial request one , state Informed Consent Form Patients must self report nausea score least 4 numeric rating scale 010 ( zero nausea ten worst possible nausea ) ; patient require vomit Patients must cancer , consultation palliative care team They must change nausea program within past 12 hour , antiemetic Patients must receive chemotherapy within 5 day , unless stable oral chemotherapy drug capecitabine ( Xeloda ) , erlotinib ( Tarceva ) , similar History substance abuse , psychiatric disorder , acquire brain injury , possibility pregnancy ( use birth control , child bearing age ) Use medication would contraindicate benzodiazepine administration Pregnant nursing Children</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>